Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to -$134872.0.

  • Iradimed's Deferred Taxes fell 718.59% to -$134872.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$292164.0, marking a year-over-year decrease of 14420.89%. This contributed to the annual value of $697652.0 for FY2024, which is 4046.87% down from last year.
  • Per Iradimed's latest filing, its Deferred Taxes stood at -$134872.0 for Q3 2025, which was down 718.59% from -$133533.0 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Deferred Taxes registered a high of $1.6 million during Q2 2024, and its lowest value of -$917373.0 during Q1 2024.
  • Over the past 5 years, Iradimed's median Deferred Taxes value was -$78656.0 (recorded in 2023), while the average stood at $46887.8.
  • Its Deferred Taxes has fluctuated over the past 5 years, first skyrocketed by 113155.05% in 2023, then plummeted by 106631.03% in 2024.
  • Over the past 5 years, Iradimed's Deferred Taxes (Quarter) stood at -$109512.0 in 2021, then tumbled by 159.54% to -$284230.0 in 2022, then soared by 124.29% to $69042.0 in 2023, then skyrocketed by 53.27% to $105823.0 in 2024, then tumbled by 227.45% to -$134872.0 in 2025.
  • Its Deferred Taxes was -$134872.0 in Q3 2025, compared to -$133533.0 in Q2 2025 and -$129582.0 in Q1 2025.